Clinical trial

Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS

NCT02965170

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-10-01

PhaseN/A

Study timeline

Study start (unknown)2016-10-01Date precision: month

Registry last updated2019-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Sponsors & collaborators

Rocky Mountain MS Research Group, LLClead sponsor

Abreos Biosciencescollaborator

Mapped research locations

Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02965170 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.